CAVA enters its September 1 earnings event with a split personality: short sellers have been quietly reducing exposure, yet options traders have just turned the most defensively positioned they've been all year.
The clearest tension sits in the options market. The put/call ratio jumped to 0.86 on Tuesday — nearly two standard deviations above its 20-day average of 0.78, and the highest reading of the past 52 weeks outside of a single prior spike at 0.90. That's a meaningful shift in a single session. The stock had already dropped 3.7% on Tuesday to close at $69.29, giving back part of a 1.5% weekly gain and leaving it 11.7% higher than a month ago. Options traders appear to be hedging into the release rather than pressing directional bets.
Short positioning tells a less aggressive story. Bears have trimmed exposure meaningfully — short interest has fallen roughly 4% over the past month to 11.0% of the free float, down from a peak near 12.7% in late July when shorts held closer to 14.9 million shares. The borrow market reflects that ease: cost to borrow is running at just 0.44%, well off the ~0.56% levels seen in mid-August, and availability has loosened to around 334% — meaning there are more than three shares available to borrow for every share already shorted. That's comfortably above the 52-week tightest level of 111%. There is no squeeze pressure in the lending market at current levels.
The Street remains broadly constructive but has been marking down its ambitions. Following the August 11 earnings print — which sent the stock up 12.8% the next day — a cluster of analysts trimmed targets. Mizuho cut to $70, DA Davidson to $75, TD Cowen to $85, and Keybanc to $95, each maintaining their ratings. On the other side, RBC Capital raised its target to $95 and Wolfe Research nudged up to $82. The mean target now sits at $84.79, about 22% above Tuesday's close — but the direction of travel has been lower, not higher. Bulls point to consistent same-store sales growth, new unit productivity, and a management team with a track record of operational focus. Bears flag the valuation: a trailing PE near 111x and an EV/EBITDA of 39.5x leave little room for execution stumbles, and lingering food-safety concerns remain a soft overhang on same-store sales momentum. The ORTEX short score of 58.8 places CAVA in a moderate bearish-positioning zone — not extreme, but not comfortable either.
One institutional detail worth noting: Artal Group, a board-represented 10% owner, sold 3 million shares at $90.30 in June — a $271 million disposal that marked a significant reduction in a concentrated position. The CEO, CFO, and founder all participated in the same-day selling cluster, though those sales were smaller and consistent with routine plan activity. Net insider disposals totalled roughly 3.1 million shares over the 90-day window. That transaction predates the stock's current $69 level, meaning the sellers got out well above where the market is trading today.
History offers two clean data points: the June print sent the stock down 13% the next day and 8% over five days; the August 11 result reversed that with a 12.8% gain and a further 10.8% over the following week. The September 1 setup — lighter short interest, defensive options positioning, and a stock that has recovered about half of its post-June losses — will be shaped almost entirely by whether same-store sales can demonstrate that the June quarter softness was a one-off rather than a trend.
See the live data behind this article on ORTEX.
Open CAVA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
